Lymphedema Study for Arm or Leg Lymphedema

• Status: Completed
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Anti-Inflammatory Agents; Ketoprofen

Criteria

Inclusion Criteria:

• a history of lymphedema of one or more limbs (unilateral or bilateral), with a duration of > 6 months.

Exclusion Criteria:

• Patients with active cancer, infection or bleeding tendency will be excluded.

• We will also exclude patients with medical contraindications to NSAIDs, including history of allergies, know gastrointestinal intolerance, or other serious systemic illness (e.g., renal failure, hepatic dysfunction, congestive heart failure, neurological or psychological impairment) that would impair the patients' ability to participate.

• Minors (<18 years of age) *>90 years of age